These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 31941015)

  • 21. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies.
    Stefan N; Häring HU; Cusi K
    Lancet Diabetes Endocrinol; 2019 Apr; 7(4):313-324. PubMed ID: 30174213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Organokines in disease.
    Chung HS; Choi KM
    Adv Clin Chem; 2020; 94():261-321. PubMed ID: 31952573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adipose tissue and ceramide biosynthesis in the pathogenesis of obesity.
    Samad F; Badeanlou L; Shah C; Yang G
    Adv Exp Med Biol; 2011; 721():67-86. PubMed ID: 21910083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatty Liver Index Associates with Relative Sarcopenia and GH/ IGF- 1 Status in Obese Subjects.
    Poggiogalle E; Lubrano C; Gnessi L; Mariani S; Lenzi A; Donini LM
    PLoS One; 2016; 11(1):e0145811. PubMed ID: 26741958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact.
    Nishikawa H; Enomoto H; Nishiguchi S; Iijima H
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deterioration of mitochondrial function in the human intercostal muscles differs among individuals with sarcopenia, obesity, and sarcopenic obesity.
    Kim KW; Baek MO; Yoon MS; Son KH
    Clin Nutr; 2021 May; 40(5):2697-2706. PubMed ID: 33933735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skeletal muscle insulin resistance: role of mitochondria and other ROS sources.
    Di Meo S; Iossa S; Venditti P
    J Endocrinol; 2017 Apr; 233(1):R15-R42. PubMed ID: 28232636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A possible link between hepatic mitochondrial dysfunction and diet-induced insulin resistance.
    Crescenzo R; Bianco F; Mazzoli A; Giacco A; Liverini G; Iossa S
    Eur J Nutr; 2016 Feb; 55(1):1-6. PubMed ID: 26476631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cardiometabolic syndrome and sarcopenic obesity in older persons.
    Dominguez LJ; Barbagallo M
    J Cardiometab Syndr; 2007; 2(3):183-9. PubMed ID: 17786082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interplay of skeletal muscle and adipose tissue: sarcopenic obesity.
    Park MJ; Choi KM
    Metabolism; 2023 Jul; 144():155577. PubMed ID: 37127228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular insight and pharmacological approaches targeting mitochondrial dynamics in skeletal muscle during obesity.
    Jheng HF; Huang SH; Kuo HM; Hughes MW; Tsai YS
    Ann N Y Acad Sci; 2015 Sep; 1350():82-94. PubMed ID: 26301786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Muscle function and fat content in relation to sarcopenia, obesity and frailty of old age--An overview.
    Buch A; Carmeli E; Boker LK; Marcus Y; Shefer G; Kis O; Berner Y; Stern N
    Exp Gerontol; 2016 Apr; 76():25-32. PubMed ID: 26785313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue-specific control of mitochondrial respiration in obesity-related insulin resistance and diabetes.
    Holmström MH; Iglesias-Gutierrez E; Zierath JR; Garcia-Roves PM
    Am J Physiol Endocrinol Metab; 2012 Mar; 302(6):E731-9. PubMed ID: 22252943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skeletal muscle mitochondrial energetics in obesity and type 2 diabetes mellitus: endocrine aspects.
    Aguer C; Harper ME
    Best Pract Res Clin Endocrinol Metab; 2012 Dec; 26(6):805-19. PubMed ID: 23168281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polycystic ovary syndrome is a risk factor for sarcopenic obesity: a case control study.
    McBreairty LE; Chilibeck PD; Gordon JJ; Chizen DR; Zello GA
    BMC Endocr Disord; 2019 Jul; 19(1):70. PubMed ID: 31262307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of sarcopenic obesity with the metabolic syndrome and insulin resistance over five years in older men: The Concord Health and Ageing in Men Project.
    Scott D; Cumming R; Naganathan V; Blyth F; Le Couteur DG; Handelsman DJ; Seibel M; Waite LM; Hirani V
    Exp Gerontol; 2018 Jul; 108():99-105. PubMed ID: 29649572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skeletal Muscle Nucleo-Mitochondrial Crosstalk in Obesity and Type 2 Diabetes.
    Devarshi PP; McNabney SM; Henagan TM
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome.
    Lim S; Taskinen MR; Borén J
    Obes Rev; 2019 Apr; 20(4):599-611. PubMed ID: 30589487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials.
    Sáez-Lara MJ; Robles-Sanchez C; Ruiz-Ojeda FJ; Plaza-Diaz J; Gil A
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27304953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Interplay between Mitochondrial Morphology and Myomitokines in Aging Sarcopenia.
    Romanello V
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.